Biologic study of the effects of lapatinib in PI3K/akt- and ras/raf/MAK-signaling pathways in HER2-positive ductal breast carcinoma in situ (DCIS).
2011 ◽
Vol 29
(15_suppl)
◽
pp. e13581-e13581
2010 ◽
2003 ◽
Vol 81
(2)
◽
pp. 129-136
◽
2020 ◽
Keyword(s):
2005 ◽
Vol 92
(9)
◽
pp. 1720-1728
◽